TCI Wealth Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

TCI Wealth Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23	Closed	-$1K	–	1620
2020 Q3	$1K	Buy	+23	New	+$547	﹤0.01%	1384

Other funds holding ORIC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

TCI Wealth Advisors's ORIC Position: Q4 2020 in Review

TCI Wealth Advisors sold out of Oric Pharmaceuticals (ORIC) in Q4 2020, closing a stake of 23 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in ORIC in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 76 funds tracked by Wall St. Rank hold ORIC as of Q4 2020.

TCI Wealth Advisors reported no remaining Oric Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
TCI Wealth Advisors sold 23 Oric Pharmaceuticals shares in Q4 2020, an estimated $1K.
TCI Wealth Advisors first reported a position in Oric Pharmaceuticals in Q3 2020 and held it in 1 quarter.
TCI Wealth Advisors's Oric Pharmaceuticals position peaked at $1K in Q3 2020.
76 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2020.

Based on TCI Wealth Advisors's 13F filing for Q4 2020, filed 21 Jan 2021.